Expression, purification and preliminary X-ray crystallographic studies of the human immunodeficiency virus 1 subtype C protease

被引:9
作者
Coman, Roxana M.
Robbins, Arthur
Goodenow, Maureen M.
McKenna, Robert
Dunn, Ben M. [1 ]
机构
[1] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA
[2] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA
来源
ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS | 2007年 / 63卷
关键词
D O I
10.1107/S174430910701161X
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Crystals of the human immunodeficiency virus 1 (HIV-1) subtype C protease (PR) complexed with the clinically used inhibitors indinavir (IDV) and nelfinavir (NFV) have been grown in the monoclinic space group P2(1), with mean unit-cell parameters a = 46.7 (+/- 0.1), b = 59.8 (+/- 0.3), c = 87.0 (+/- 0.4) angstrom, beta = 95.2 (+/- 0.5)degrees. The crystals of both complexes have been shown to diffract X-rays to 2.3 angstrom resolution. The diffraction data for the subtype C PR complexes with IDV and NFV were subsequently processed and reduced, with overall R-sym values of 8.4 and 11.4%, respectively. Based on the unit-cell volumes, molecular-replacement results and packing considerations, there are two protease homodimers per crystallographic asymmetric unit in each of the complexes. The data were initially phased using a model based on the crystal structure of HIV-1 subtype B PR; the structures have been determined and further refinement and analysis are in progress. These structures and subsequent studies with other inhibitors will greatly aid in correlating the amino-acid variation between the different HIV PRs and understanding their differential sensitivity and resistance to current drug therapy.
引用
收藏
页码:320 / 323
页数:4
相关论文
共 41 条
  • [1] Protease mutation M89I/V is linked to therapy failure in patients infected with the HIV-1 non-B subtypes C, F or G
    Abecasis, AB
    Deforche, K
    Snoeck, J
    Bacheler, LT
    McKenna, P
    Carvalho, AP
    Gomes, P
    Camacho, RJ
    Vandamme, AM
    [J]. AIDS, 2005, 19 (16) : 1799 - 1806
  • [2] THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY
    BAILEY, S
    [J]. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 : 760 - 763
  • [3] Molecular dynamics simulations applied to the study of subtypes of HIV-1 protease common to Brazil, Africa, and Asia
    Batista, PR
    Wilter, A
    Durham, EHAB
    Pascutti, PG
    [J]. CELL BIOCHEMISTRY AND BIOPHYSICS, 2006, 44 (03) : 395 - 404
  • [4] Crystallography & NMR system:: A new software suite for macromolecular structure determination
    Brunger, AT
    Adams, PD
    Clore, GM
    DeLano, WL
    Gros, P
    Grosse-Kunstleve, RW
    Jiang, JS
    Kuszewski, J
    Nilges, M
    Pannu, NS
    Read, RJ
    Rice, LM
    Simonson, T
    Warren, GL
    [J]. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1998, 54 : 905 - 921
  • [5] Resistance-associated mutations in the human immunodeficiency virus type 1 subtype C protease gene from treated and untreated patients in the United Kingdom
    Cane, PA
    de Ruiter, A
    Rice, P
    Wiselka, M
    Fox, R
    Pillay, D
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (07) : 2652 - 2654
  • [6] Genotypic and phenotypic evidence of different drug-resistance mutation patterns between B and non-B subtype isolates of human immunodeficiency virus type 1 found in Brazilian patients failing HAART
    Caride, E
    Hertogs, K
    Larder, B
    Dehertogh, P
    Brindeiro, R
    Machado, E
    De Sá, CAM
    Eyer-Silva, WA
    Sion, FS
    Passioni, LFC
    Menezes, JA
    Calazans, AR
    Tanuri, A
    [J]. VIRUS GENES, 2001, 23 (02) : 193 - 202
  • [7] Antiretroviral therapy for HIV infection in 1997 - Updated recommendations of the International AIDS Society USA panel
    Carpenter, CCJ
    Fischl, MA
    Hammer, SM
    Hirsch, MS
    Jacobsen, DM
    Katzenstein, DA
    Montaner, JSG
    Richman, DD
    Saag, MS
    Schooley, RT
    Thompson, MA
    Vella, S
    Yeni, PG
    Volberding, PA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (24): : 1962 - 1969
  • [8] *CDC, 2006, ANN PHARMACOTHER, V40, P1708
  • [9] Analysis of HIV-1CRF_01 A/E protease inhibitor resistance: Structural determinants for maintaining sensitivity and developing resistance to atazanavir
    Clemente, JC
    Coman, RM
    Thiaville, MM
    Janka, LK
    Jeung, JA
    Nukoolkarn, S
    Govindasamy, L
    Agbandje-McKenna, M
    McKenna, R
    Leelamanit, W
    Goodenow, MM
    Dunn, BM
    [J]. BIOCHEMISTRY, 2006, 45 (17) : 5468 - 5477
  • [10] Collier AC, 1996, ADV EXP MED BIOL, V394, P355